Justifying the risks of COVID-19 challenge trials: The analogy with organ donation
In the beginning of the COVID pandemic, researchers and bioethicists called for human challenge trials to hasten the development of a vaccine for COVID. However, the fact that we lacked a specific, highly effective treatment for COVID led many to argue that a COVID challenge trial would be unethical...
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2022
|
| In: |
Bioethics
Year: 2022, Volume: 36, Issue: 1, Pages: 100-106 |
| IxTheo Classification: | NCH Medical ethics NCJ Ethics of science |
| Further subjects: | B
Covid-19
B human challenge trials B research ethics B Organ Donation B Clinical Trials |
| Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1782405054 | ||
| 003 | DE-627 | ||
| 005 | 20220119154245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211217s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12889 |2 doi | |
| 035 | |a (DE-627)1782405054 | ||
| 035 | |a (DE-599)KXP1782405054 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Jayaram, Athmeya |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Justifying the risks of COVID-19 challenge trials: The analogy with organ donation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a In the beginning of the COVID pandemic, researchers and bioethicists called for human challenge trials to hasten the development of a vaccine for COVID. However, the fact that we lacked a specific, highly effective treatment for COVID led many to argue that a COVID challenge trial would be unethical and we ought to pursue traditional phase III testing instead. These ethical objections to challenge trials may have slowed the progress of a COVID vaccine, so it is important to evaluate their merit. One common way of doing so is to make an analogy to other social practices that are relevantly similar and which we currently sanction. We submit that non-directed live organ donation (NDLOD) is a promising analogy. After arguing that the risks to volunteers for each activity appear similar, we explore potential disanalogies that would undermine the comparison. We note that there are differences in both the kind and certainty of benefit secured by NDLOD compared to challenge trials. We conclude these differences are insufficient to make NDLOD permissible and challenge trials impermissible. Ultimately, if we think the risks associated with NDLOD are ethically permissible, then we should think the same of the risks associated with COVID challenge trials. | ||
| 601 | |a COVID-19 | ||
| 601 | |a Challenger | ||
| 650 | 4 | |a research ethics | |
| 650 | 4 | |a Organ Donation | |
| 650 | 4 | |a human challenge trials | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Clinical Trials | |
| 652 | |a NCH:NCJ | ||
| 700 | 1 | |a Sparks, Jacob |e VerfasserIn |4 aut | |
| 700 | 1 | |a Callies, Daniel |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 36(2022), 1, Seite 100-106 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2022 |g number:1 |g pages:100-106 |
| 856 | |u https://philpapers.org/archive/JAYJTR-11.pdf |x unpaywall |z Vermutlich kostenfreier Zugang |h repository [oa repository (via OAI-PMH title and first author match)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.12889 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12889 |x Verlag |z kostenfrei |3 Volltext |
| 935 | |a mteo | ||
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4021397795 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1782405054 | ||
| LOK | |0 005 20220119154245 | ||
| LOK | |0 008 211217||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-12-16#03EB74926DFB6548F623751535072EC2477E3A81 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a zota | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 1550736582 |a NCJ | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||